Literature DB >> 17197240

Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells.

Jose A Villadangos1, William R Heath, Francis R Carbone.   

Abstract

The entry of exogenous antigen into the MHC class I-restricted cross-presentation pathway can contribute to CD8(+) T cell tolerance and immunity, in particular to peripheral self-antigens or selected viruses and bacteria showing restricted tissue tropism. Dendritic cells are the key cross-presenting cells and, as such, they are thought to carry specialized machinery dedicated to this purpose. Two recent papers describe intracellular components tailored to the dendritic cell cross-presentation pathway.

Entities:  

Mesh:

Year:  2007        PMID: 17197240     DOI: 10.1016/j.it.2006.12.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  15 in total

1.  A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Authors:  John T Hunzeker; Michael D Elftman; Jennifer C Mellinger; Michael F Princiotta; Robert H Bonneau; Mary E Truckenmiller; Christopher C Norbury
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

2.  Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.

Authors:  Giulia Freer; Donatella Matteucci; Paola Mazzetti; Francesca Tarabella; Valentina Catalucci; Enrica Ricci; Antonio Merico; Leonia Bozzacco; Mauro Pistello; Mauro Bendinelli
Journal:  Clin Vaccine Immunol       Date:  2008-01-23

3.  The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation.

Authors:  Verena Böhm; Christian O Simon; Jürgen Podlech; Christof K Seckert; Dorothea Gendig; Petra Deegen; Dorothea Gillert-Marien; Niels A W Lemmermann; Rafaela Holtappels; Matthias J Reddehase
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

Review 4.  γδ T-APCs: a novel tool for immunotherapy?

Authors:  Bernhard Moser; Matthias Eberl
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

Review 5.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 6.  Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Authors:  Antonella Sistigu; Sophie Viaud; Nathalie Chaput; Laura Bracci; Enrico Proietti; Laurence Zitvogel
Journal:  Semin Immunopathol       Date:  2011-05-25       Impact factor: 11.759

7.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

Review 8.  Endogenous and tumour-derived microRNAs regulate cross-presentation in dendritic cells and consequently cytotoxic T cell function.

Authors:  Siambi Kikete; Xiaoqian Chu; Li Wang; Yuhong Bian
Journal:  Cytotechnology       Date:  2016-05-18       Impact factor: 2.058

9.  Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.

Authors:  Annabell Bachem; Steffen Güttler; Evelyn Hartung; Frédéric Ebstein; Michael Schaefer; Astrid Tannert; Abdulgabar Salama; Kamran Movassaghi; Corinna Opitz; Hans W Mages; Volker Henn; Peter-Michael Kloetzel; Stephanie Gurka; Richard A Kroczek
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

Review 10.  Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.

Authors:  Yu-Zhe Chen; Xing-Lei Yao; Yasuhiko Tabata; Shinsaku Nakagawa; Jian-Qing Gao
Journal:  Clin Dev Immunol       Date:  2010-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.